共 39 条
Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients
被引:8
|作者:
Locke, J. E.
[1
]
Shelton, B. A.
[1
]
Reed, R. D.
[1
]
MacLennan, P. A.
[1
]
Mehta, S.
[1
]
Sawinski, D.
[2
]
Segev, D. L.
[3
]
机构:
[1] Univ Alabama Birmingham, Comprehens Transplant Inst, Birmingham, AL 35233 USA
[2] Univ Penn, Comprehens Transplant Ctr, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
基金:
美国国家卫生研究院;
关键词:
clinical research;
practice;
health services and outcomes research;
infectious disease;
kidney transplantation;
nephrology;
immune deficiency;
infection and infectious agents;
viral: human immunodeficiency virus (HIV);
acquired immunodeficiency syndrome (AIDS);
viral: hepatitis C;
RENAL-TRANSPLANTATION;
ACUTE REJECTION;
HIV;
IMMUNOSUPPRESSION;
SURVIVAL;
OUTCOMES;
LIVER;
D O I:
10.1111/ajt.13847
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
For some patient subgroups, human immunodeficiency virus (HIV) infection has been associated with worse outcomes after kidney transplantation (KT); potentially modifiable factors may be responsible. The study goal was to identify factors that predict a higher risk of graft loss among HIV-positive KT recipients compared with a similar transplant among HIV-negative recipients. In this study, 82 762 deceased donor KT recipients (HIV positive: 526; HIV negative: 82 236) reported to the Scientific Registry of Transplant Recipients (SRTR) (2001-2013) were studied by interaction term analysis. Compared to HIV-negative recipients, the hepatitis C virus (HCV) amplified risk 2.72-fold among HIV-positive KT recipients (adjusted hazard ratio [aHR]: 2.72, 95% confidence interval [CI]: 1.75-4.22, p < 0.001). Forty-three percent of the excess risk was attributable to the interaction between HIV and HCV (attributable proportion of risk due to the interaction [AP]: 0.43, 95% CI: 0.23-0.63, p = 0.02). Among HIV-positive recipients with more than three HLA mismatches (MMs), risk was amplified 1.80-fold compared to HIV-negative (aHR: 1.80, 95% CI: 1.31-2.47, p < 0.001); 42% of the excess risk was attributable to the interaction between HIV and more than three HLA MMs (AP: 0.42, 95% CI: 0.24-0.60, p = 0.01). High-HIV-risk (HIV-positive/HCV-positive HLAwith more than three MMs) recipients had a 3.86-fold increased risk compared to low-HIV-risk (HIV-positive/HCV-negative HLA with three or fewer MMs)) recipients (aHR: 3.86, 95% CI: 2.37-6.30, p < 0.001). Avoidance of more than three HLA MMs in HIV-positive KT recipients, particularly among coinfected patients, may mitigate the increased risk of graft loss associated with HIV infection. Avoidance of HLA mismatches in HIV-infected kidney transplant recipients, particularly among those coinfected with hepatitis C, may mitigate the increased risk of graft loss associated with HIV infection.
引用
收藏
页码:2377 / 2383
页数:7
相关论文